Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jingting Min, Chirong Long, Lu Zhang, Jiakang Duan, Honglian Fan, Fei Chu & Zhenghong Li. (2022) c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549. Bioengineered 13:4, pages 9232-9248.
Read now
Read now
Articles from other publishers (12)
Yi-xin Hu, Cui-ju Yan, Miao Yun, Wei Zheng, Xue-bin Zou, Ya-fang Zhang, Ru-shuang Mao, Ling-ling Li & Jian-hua Zhou. (2023) Contrast-enhanced ultrasound liver imaging reporting and data system v2017: patient outcomes after treatment for early-stage hepatocellular carcinoma nodules with category 3-5 and category M. The British Journal of Radiology.
Crossref
Crossref
Yang Liu, Xia Xiao, Jingying Wang, Yitong Wang & Yanhui Yu. (2022) Silencing CircEIF3I/miR-526b-5p Axis Epigenetically Targets HGF/c-Met Signal to Hinder the Malignant Growth, Metastasis and Angiogenesis of Hepatocellular Carcinoma. Biochemical Genetics 61:1, pages 48-68.
Crossref
Crossref
Qiang Guo, Zhiwu Dong, Lixin Jiang, Lei Zhang, Ziyao Li & Dongmo Wang. (2022) Establishment and validation of an ultrasound‐based nomogram with risk stratification for short disease‐free survival in breast cancer. Journal of Clinical Ultrasound 51:1, pages 134-147.
Crossref
Crossref
Qiu-Ping Ma, Xue-lei He, Kai Li, Jin-fen Wang, Qing-Jing Zeng, Er-Jiao Xu, Xu-qi He, Shuo-yang Li, Wang Kun, Rong-Qin Zheng & Jei Tian. (2021) Dynamic Contrast-Enhanced Ultrasound Radiomics for Hepatocellular Carcinoma Recurrence Prediction After Thermal Ablation. Molecular Imaging and Biology 23:4, pages 572-585.
Crossref
Crossref
Wei Meng & Tao Chen. (2021) Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review). Oncology Reports 46:3.
Crossref
Crossref
Li-xiang Zhang, Pan-quan Luo, Lei Chen, Dong-da Song, A-man Xu, Peng Xu & Jia Xu. (2021) Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy. Frontiers in Oncology 10.
Crossref
Crossref
Shenjun Yuan, Yuyuan Gong, Ruobing Chen, Juan Du, Hongfeng Zhang & Tao Chen. (2020) Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway. Biomedicine & Pharmacotherapy 132, pages 110867.
Crossref
Crossref
Haiyu Wang, Benchen Rao, Jiamin Lou, Jianhao Li, Zhenguo Liu, Ang Li, Guangying Cui, Zhigang Ren & Zujiang Yu. (2020) The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Shiyun Peng, Hong Ding, Tiantian Fu, Bengang Wang, Wenping Wang & Jinzhu Zhou. (2019) Savitzky-Golay filter based contrast-enhanced ultrasound quantification in hepatic tumors: Methodology and its correlation with tumor angiogenesis. Clinical Hemorheology and Microcirculation 73:2, pages 271-282.
Crossref
Crossref
Bing Liu, Zheng‑Zhi Liu, Mei‑Ling Zhou, Jian‑Wei Lin, Xue‑Mei Chen, Zhu Li, Wen‑Bin Gao, Zhen‑Dong Yu & Tao Liu. (2019) Development of c‑MET‑specific chimeric antigen receptor‑engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells. Molecular Medicine Reports.
Crossref
Crossref
Hai Shang, Zhi Hao, Xi Fu, Xiang Hua, Zuo Ma, Fu Ai, Zhao Feng, Kun Wang, Wen Li & Bo Li. (2018) Intermedin promotes hepatocellular carcinoma cell proliferation through the classical Wnt signaling pathway. Oncology Letters.
Crossref
Crossref
Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, Hyun Joo Jang & Jin Lee. (2017) Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review. Oncotarget 8:52, pages 90351-90357.
Crossref
Crossref